CorMedix Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$826M
↑+595.1% +$707Mvs FY2024
Total Liabilities
$421M
↑+1130.9% +$387Mvs FY2024
Equity
$405M
↑+378.8% +$321Mvs FY2024
Cash
$145M
↑+256.3% +$104Mvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $826M | $119M |
| Current Assets | $367M | $115M |
| Cash | $145M | $41M |
| ST Investments | $4M | $11M |
| Receivables | $171M | $52M |
| Inventory | $30M | $8M |
| Other Current | $18M | $4M |
| Non-Current Assets | $459M | $4M |
| PPE | $6M | $2M |
| Goodwill | $30M | $0 |
| Intangibles | $379M | $2M |
| Investments | $0 | $0 |
| Other Non-Current | $44M | $598K |
| Total Liab+Eq | $826M | $119M |
| Current Liab. | $174M | $34M |
| Accounts Payable | $8M | $2M |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $166M | $32M |
| Non-Current Liab. | $247M | $349K |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $247M | $349K |
| Equity | $405M | $85M |
| Retained Earnings | $177M | $340M |
| Other Equity | $229M | $0 |
QuarterCharts · SEC EDGAR data · CRMD · Comparing FY2025 vs FY2024